Caption Management, LLC Supernus Pharmaceuticals, Inc. Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$26.37 - $34.22 $316,440 - $410,640	-12,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$23.54 - $31.39 $282,480 - $376,680	12,000 New	12,000 $320,000
Q1 2021 May 17, 2021	SELL	$24.15 - $31.45 $1.4 Million - $1.82 Million	-58,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$17.7 - $25.81 $1.03 Million - $1.5 Million	58,000 New	58,000 $1.46 Million
Q2 2019 Aug 13, 2019	SELL	$29.96 - $38.87 $581,224 - $754,078	-19,400 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$32.77 - $41.99 $642,292 - $823,004	-19,600 Reduced 50.26%	19,400 $681,000
Q4 2018 Jan 30, 2019	BUY	$30.84 - $49.51 $1.2 Million - $1.93 Million	39,000 New	39,000 $1.3 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.